VSI Spring 2019 Newsletter
Bibliography and Sources

Back to Newsletter

Amer AA, Mchepange UO, Gao XH, et al. Hidden victims of childhood vitiligo: impact on parents’ mental health and quality of life. Acta Derm Venereol. 2015 Mar;95(3):322-5.  https://www.ncbi.nlm.nih.gov/pubmed/25110968

American Academy of Allergy, Asthma, & Immunology. Atopy Definition.  https://www.aaaai.org/conditions-and-treatments/conditions-dictionary/atopy

Cadmus SD, Lundgren AD, Ahmed AM. Therapeutic interventions to lessen the psychosocial effect of vitiligo in children: A review. Pediatr Dermatol. 2018 Jul;35(4):441-447. https://www.ncbi.nlm.nih.gov/pubmed/29766546

Cameron D. What is that Smell? Danielcameronmd.com. http://danielcameronmd.com/whats-that-smell/

Cherry K. Erik Erikson’s Stages of Psychosocial Development. Verywellmind.com. Updated April 4, 2019. https://www.verywellmind.com/erik-eriksons-stages-of-psychosocial-development-2795740

Deisinger PJ, Hill TS, English JC. Human Exposure to Naturally Occurring Hydroquinone
J Toxicol Environ Health. 1996 Jan;47(1):31-46. Published online: 30 Nov 2010. https://www.ncbi.nlm.nih.gov/pubmed/8568910

Environment Canada, Health Canada. Proposed Risk Management Approach for 1,4-Benzenediol Hydroquinone
Chemical Abstract Service (CAS) Registry Number: 123-31-9. July 2008. https://www.ec.gc.ca/ese-ees/3814237A-D088-4824-9ECB-643E32471DCC/batch1_123-31-9_en.pdf

Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B. Silymarin impacts on immune system as an immunomodulator: One key for many locks. Int Immunopharmacol. 2017 Sep;50:194-201. Epub 2017 Jun 30. https://www.ncbi.nlm.nih.gov/pubmed/28672215

Eudowe J. Stress and Anxiety Can Be Contagious! Integrative Behavioral Health, LLC. May 9 2017. http://ibhwestport.com/stress-and-anxiety-can-be-contagious/

Ezzedine K, Silverberg N. A Practical Approach to the Diagnosis and Treatment of Vitiligo in Children.
Pediatrics. 2016 Jul;138(1). Epub 2016 Jun 21. https://www.ncbi.nlm.nih.gov/pubmed/27328922

Gey A, Diallo A, Seneschal J, et al. Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. Br J Dermatol. 2013 Apr;168(4):756-61. https://www.ncbi.nlm.nih.gov/pubmed/23253044

Halder R, Grimes P, Cowan C et al. Childhood Vitiligo. JAAD. Volume 16, Issue 5, Part 1, Pages 948–954. 1987 May. https://www.jaad.org/article/S0190-9622(87)70119-4/fulltext

Healthline. 7 Science-Based Benefits of Milk Thistle. https://www.healthline.com/nutrition/milk-thistle-benefits

Healthline. Hyperosmia. Healthline.com. https://www.healthline.com/health/hyperosmia

Jowkar F, Godarzi H, Parvizi MM. Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy alone. J Dermatolog Treat. 2019 Apr 2:1-5. [Epub ahead of print https://www.ncbi.nlm.nih.gov/pubmed/30935260

Krupa Shankar DS, Shashikala K, Madala R. Indian Dermatol Online J. 2012 May-Aug; 3(2): 114–118. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481882/#ref46

Lee DY, Kim CR, Park JH, Lee JH. The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment. Int J Dermatol. 2011 Aug;50(8):925-7. https://www.ncbi.nlm.nih.gov/pubmed/21781062

Leslie D, Lipsky P, Notkins AL. Autoantibodies as predictors of Disease. J Clin Invest. 2001 Nov 15; 108(10): 1417–1422. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC209428/

Majid I. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. Photodermatol Photoimmunol Photomed. 2010 Oct;26(5):230-4. https://www.ncbi.nlm.nih.gov/pubmed/20831696

Manzoni AP, Weber MB, Nagatomi AR, et al. Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders. An Bras Dermatol. 2013 Nov-Dec; 88(6): 894–899.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900338/

Nordlund JJ, Grimes PE, Ortonne JP. The safety of hydroquinone. J Eur Acad Dermatol Venereol. 2006 Aug;20(7):781-7. https://www.ncbi.nlm.nih.gov/pubmed/16898897

Osborn C. Halo Nevus or Mole. Healthline. Medically reviewed 1/8/18.  https://www.healthline.com/health/halo-nevus

Saini R. Hyperosmia: Causes, Symptoms, Diagnosis and Treatment. Healthvista.org. https://healthvista.org/hyperosmia/#Causes_of_Hyperosmia

Shin JY, Kim DW, Park CW, et al. An Educational Program that Contributes to Improved Patient and Parental Understanding of Atopic Dermatitis. Ann Dermatol. 2014 Feb; 26(1): 66–72. Published online 2014 Feb 17.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956797/

Siegfried EC, Jaworski JC, Hebert AA. Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. Am J Clin Dermatol. June 2013;14:163–78. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669499/

Silverberg JI, Silverberg NB. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color. J Drug Dermatol. 2011 May;10(5):507-10. https://www.ncbi.nlm.nih.gov/pubmed/21533297

Silverberg NB. Recent advances in childhood vitiligo. Clin Dermatol. 2014 Jul-Aug;32(4):524-30. Epub 2014 Feb 28. https://www.ncbi.nlm.nih.gov/pubmed/25017463

Smith MK, Mohammad TF, Hamzavi IH. Assessment of Dietary Supplementation in the Treatment of Vitiligo. The Open Dermatology Journal. 2017 11(1), 12-21. https://pdfs.semanticscholar.org/7e49/840284519bea54b07d563c8067863b3d61f9.pdf

Spritz RA. Shared Genetic Relationships Underlying Generalized Vitiligo and Autoimmune Thyroid Disease. Thyroid. 2010 Jul; 20(7): 745–754. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935342/

Taïeb  A. Vitiligo as an inflammatory skin disorder: a therapeutic perspective. Pigment Cell and Melanoma Research. Volume 25, Issue1. January 2012, pp 9-13. First published: 19 November 2011.
https://onlinelibrary.wiley.com/doi/full/10.1111/j.1755-148X.2011.00939.x

Van Driessche F, Silverberg N. Current Management of Pediatric Vitiligo. Paediatr Drugs. 2015 Aug;17(4):303-13. https://www.ncbi.nlm.nih.gov/pubmed/26022363